Back to top
more

Axonics (AXNX)

(Delayed Data from NSDQ)

$66.54 USD

66.54
484,280

-0.10 (-0.15%)

Updated Apr 25, 2024 04:00 PM ET

After-Market: $66.54 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 251)

Industry: Medical Info Systems

Better trading starts here.

Zacks News

All You Need to Know About Axonics (AXNX) Rating Upgrade to Buy

Axonics (AXNX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Axonics (AXNX) Gets CE Mark for Sacral Neuromodulation System

Axonics' (AXNX) fourth-generation rechargeable Sacral Neuromodulation system will reduce the frequency of patient recharges significantly. The new form factor ensures ease of use.

Axonics Modulation Technologies (AXNX) Q4 Earnings and Revenues Surpass Estimates

Axonics (AXNX) delivered earnings and revenue surprises of 116.67% and 0.37%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

American Well Corporation (AMWL) Reports Q4 Loss, Tops Revenue Estimates

American Well Corporation (AMWL) delivered earnings and revenue surprises of 10.53% and 1%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks.com featured highlights include Axonics, Enerpac Tool Group, Cardinal Health and Acuity Brands

Axonics, Enerpac Tool Group, Cardinal Health and Acuity Brands are part of the Zacks Screen of the Week article.

Santanu Roy  headshot

4 Stocks Backed by High Efficiency to Enrich Your Portfolio

Invest in companies like Axonics (AXNX), Enerpac Tool Group (EPAC), Cardinal Health (CAH) and Acuity Brands (AYI) due to higher efficiency levels.

Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?

Here is how Elevance Health (ELV) and Axonics Modulation Technologies (AXNX) have performed compared to their sector so far this year.

Nilanjan Banerjee headshot

Buy These 4 Low-Beta Stocks to Counter Market Volatility

It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Virco Mfg (VIRC), Galapagos NV (GLPG), Axonics (AXNX) and Stride (LRN) are well-poised to gain.

Zacks.com featured highlights Axonics, Bel Fuse and Thermon

Axonics, Bel Fuse and Thermon have been highlighted in this Screen of The Week article.

Santanu Roy  headshot

3 Stocks Backed by High Efficiency to Increase Portfolio Returns

Invest in stocks of Axonics (AXNX), Bel Fuse (BELFB) and Thermon (THR) to tap their high-efficiency levels.

Wall Street Analysts Believe Axonics (AXNX) Could Rally 25.1%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 25.1% in Axonics (AXNX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

New Strong Buy Stocks for October 31st

SPOT, USAP, COOP, JILL and AXNX have been added to the Zacks Rank #1 (Strong Buy) List on October 31, 2023.

Axonics Modulation Technologies (AXNX) Q3 Earnings and Revenues Top Estimates

Axonics (AXNX) delivered earnings and revenue surprises of 260% and 2.41%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Nalak Das headshot

5 Top Stocks Set to Beat Q3 Earnings Estimates on Monday

We have narrowed our search to five stocks that are set to declare third-quarter earnings on Monday. These are: XPO, ON, WELL, ACGL, AXNX.

IRhythm Technologies (IRTC) Expected to Beat Earnings Estimates: Should You Buy?

IRhythm Technologies (IRTC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Axonics Modulation Technologies (AXNX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Axonics (AXNX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What's in Store for Thermo Fisher (TMO) in Q3 Earnings?

Thermo Fisher (TMO) will likely gain from strong Analytical Instrument business performance and latest launches.

Axonics Modulation Technologies (AXNX) Reports Q2 Loss, Tops Revenue Estimates

Axonics (AXNX) delivered earnings and revenue surprises of -25% and 7.67%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Axonics Modulation Technologies (AXNX) Reports Q1 Loss, Tops Revenue Estimates

Axonics (AXNX) delivered earnings and revenue surprises of 44.12% and 9.85%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Axonics Modulation Technologies (AXNX) Surpasses Q4 Earnings and Revenue Estimates

Axonics (AXNX) delivered earnings and revenue surprises of 104.35% and 0.14%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Bilibili (BILI) to Report Q4 Earnings: What's in the Cards?

Bilibili's (BILI) fourth-quarter 2022 results are likely to reflect strength in mobile gaming revenues. However, increasing channel and marketing expenses are expected to have kept margins under pressure.

Fulgent Genetics, Inc. (FLGT) Reports Q4 Loss, Tops Revenue Estimates

Fulgent Genetics, Inc. (FLGT) delivered earnings and revenue surprises of 14.29% and 13.90%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

BOX Gears Up for Q4 Earnings: Here's What You Should Know

BOX's fourth-quarter fiscal 2023 results are likely to reflect strength in its Content Cloud amid headwinds.

Why Axonics (AXNX) Might Surprise This Earnings Season

Axonics (AXNX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Agilent Technologies (A) to Post Q1 Earnings: What's in Store?

Agilent Technologies (A) first-quarter fiscal 2023 results are likely to reflect strength in LSAG, ACG and DGG segments.